Edition:
United States

Novogen Ltd (NVGN.OQ)

NVGN.OQ on NASDAQ Stock Exchange Capital Market

3.27USD
17 Aug 2017
Change (% chg)

-- (--)
Prev Close
$3.27
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,897
52-wk High
$9.72
52-wk Low
$2.67

NVGN.OQ

Chart for NVGN.OQ

About

Novogen Limited (Novogen) is an oncology biotechnology company, which is focused on developing cancer treatments. The Company is primarily engaged in pharmaceutical research and development. Novogen has two drug technology platforms (the Superbenzopyran (SBP) technology and Anti-tropomyosin (ATM)) yielding various drug... (more)

Overall

Beta: 0.08
Market Cap(Mil.): $16.00
Shares Outstanding(Mil.): 4.83
Dividend: --
Yield (%): --

Financials

  NVGN.OQ Industry Sector
P/E (TTM): -- 78.89 32.56
EPS (TTM): -9.00 -- --
ROI: -29.63 2.83 14.89
ROE: -33.93 5.09 16.13

BRIEF-Novogen Ltd provides update to investors on a review of business operations

* Novogen Ltd - provide an update to investors on a review of business operations recently completed by board and management team

Aug 14 2017

BRIEF-Novogen says chairman John O'connor to step down

* Chairman, john o'connor and non-executive director, ian phillips step down from novogen board

Jun 07 2017

BRIEF-Novogen terminates ATM-3507 preclinical development program

* Novogen terminates ATM-3507 preclinical development program

Apr 05 2017

BRIEF-Novogen says CFO Cristyn Humphreys will leave company

* Cristyn Humphreys, chief financial officer (CFO) at Novogen will leave Novogen later this month to assume a new role outside industry

Mar 09 2017

Earnings vs. Estimates